FDA Investigator Kelley
Kelley has inspections in 1 countries as of 04 Aug 2023. Kelley has collaborated with a combinined 3359 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
168
Last Inspection Date:
04 Aug 2023
Investigator Role:
FDA Investigator (Contractor)
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aaron J Adler,
Ademola O Daramola,
Alan L Truong,
Alan P Kurtzberg,
Alejandra Mcclellan,
Alexandra B Pitkin,
Amalia C Himaya,
Amanda L Fyles,
Amir Alavi,
Anderson,
Andrew K Haack, PhD,
Andy B Lee,
Arsen Karapetyan,
Ashar P Parikh,
Ayodele I Ojediran,
Babajide Michael Osunsanmi,
Benjamin S Liao,
Bichsa T Tran,
Binh T Nguyen,
Brian P Putz,
Bryan A Galvez,
Bryce A Hammer,
Bush,
Carla J Lundi,
Carolina D Vasquez,
Carr Sharpe,
Carrie A Hughes,
Caryn M Everly,
Caryn M Mcnab,
Cecilia H Kieu,
Celena Ngo,
Christine A Harman, PhD,
Christopher D Washington,
Christopher J Freebairn,
Christopher M Jenner,
Christopher R Czajka,
Claudia Mperez Kasmarski,
Comyar Shoghi,
Crystal Monroy,
Daniel Velasquez,
Darren S Brown,
David H Hsu,
Deborah A Greco,
Deborah M Trout,
Deborah W Hsu,
Diane Cvan Leeuwen,
Diane R Weidley,
Djamila Harouaka,
Doan T Nguyen, PharmD,
Dogbeda F Mackenzie,
Donna Ltartaglino Besone,
Donna Mwilliams Hill,
Dr. Chunchang Fang,
Durell L Giles,
Erika V Butler,
Eugene Y Chang,
Evelyn Wong,
Garciam,
Gary R Wong,
Gilbert T Salud,
Greg K Keshishyan,
Guillermo,
Gunneet Kaur,
Heidy C Perales,
Hoover,
Hung H Do, MS,
Jacob W Reynolds,
Jai P Singh,
James P Stumpff,
James R Fleckenstein,
Jamie M Du,
Jeff M Uriarte,
Jeffrey P Raimondi,
Jennifer M Gogley,
Jenny L Chisem,
Jenny L Mccardell,
Jessica B Clark,
Jinnie Kokiatkulkij,
Jocelyn E Massey,
Joey V Quitania,
John A Gonzalez,
John P Jorgensen,
John R Myung,
Jolanna A Norton,
Juan J Casado,
Juanita Banuelos,
Judy C Nepsa,
Julie A Stocklin,
Julie Rorberg,
Ka L Wong,
Kari M Johansen,
Katherine E Jacobitz,
Kathy Chiu,
Keeshunna D Daniels,
Kelvin Cheung,
Kelvin X Sanders,
Kevin Lee,
Kevin N Tran,
Kham Phommachanh,
Khoa Nathanv Tran,
Kim Lthomas Cruse,
Kouros Kangarli,
Kristin M Abaonza,
Lakecha N Lewis,
Lance A Finnical,
Langer,
Lanita F Kelley,
Leonard H Lavi,
Lillian S Wu,
Lilly O Barton,
Liming Zhang,
Linda F Murphy,
Linda Thai,
Lisa Shin,
LT Richard A Lyght,
Lucas B Leake,
Marcus F Yambot,
Mark C Saale,
Marlo Ianm Alintanahin,
Matthew J Johnson,
Matthew R Clabeaux,
Maxyne Lam,
Maxyne T Lam,
Michael D Garcia,
Michael D Kawalek,
Michael S Call,
Michael Shanks, MS,
Miguel A Martinez,
Mihaly S Ligmond,
Minh D Phan,
Nancy E Byerly,
Natalie J Ayoub,
Nicholas L Hunt,
Patricia F Alberico,
Paul A Bonneau,
Phillip Terrazas,
Rachel C Stanton,
Rafael A Kaup,
Rafael Movsesyan,
Richmond K Yip,
Robert T Lorenz,
Rocio Guzman Velazquez,
Roger F Zabinski,
Romero,
Rowena S Nguyen,
Rumany C Penn, PharmD,
Ryan Burger,
Ryan J Borges,
Saied A Asbagh,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Sara H Gabel,
Sara Jdent Acosta,
Scott K Zika,
Scott N Lim,
Scott T Ballard,
Sean P Desbrow,
Selene T Torres,
Sherrie M La,
Sonia R Peterson,
Sonya L Karsik,
Stacie A Woods,
State Agency,
Stephanie A Slater, MS,
Steven E Porter, Jr,
Sundy Ven,
Sunitha K Rajaram, PhD,
Susanna N Choi,
Taichun Qin, PhD,
Tamala P Bogan,
Tamala P Magee,
Teresa I Navas,
Terri L Dodds,
Thao T Kwan,
Thao X Tran,
Theresa Kirkham (NMI),
Timothy P Lafave,
Trudy R Papson,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Uttaniti Lischumroon,
Vaishali J Patel,
Vashti E Bocker,
Victor H Loo,
Virgilio F Pacio, CSO,
Walden H Lee,
Wenzheng Zhang,
Yasamin Ameri,
Yen Tso Kuo,
Youkeun Kim,
Yumi J Hiramine,
Yvette E Elacio,
Yvette E Guillermo,
Yvette Mlacour Davis,
Yvonne T Lacour,
Zachary A Bogorad,
Zachary L Miller
Kelley's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2010 | EIR | PYRAMID Laboratories, Inc. - EIR, 2010-03-08 |
| November, 2010 | EIR | Cardinal Health 414, LLC - EIR, 2010-11-18 |
| June, 2009 | FDA 483 | Quantum Labs, LLC - Form 483, 2009-06-26 |
| July, 2009 | FDA 483 | Valley Respiratory & Medical - Form 483, 2009-07-15 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more